TABLE 2.
TC mg/dL N=113 |
LDL mg/dL N=107 |
HDL mg/dL N=115 |
||
---|---|---|---|---|
Correlate | N* | Mean^ | ||
Overall Mean | 118.9 | 51.8 | 30.9 | |
Females | 56 | 120.7 | 56.9 | 28.4 |
Males | 57 | 117.1 | 46.8 | 33.4¶ |
Age <4 months | 74 | 124.1 | 54.4 | 30.6 |
Age ≥4 months | 39 | 109.1 | 46.7 | 31.4 |
WHO Stage 1/2 | 57 | 124.6 | 61.9 | 30.5 |
WHO Stage 3/4 | 53 | 112.8 | 42.8§ | 31.1 |
WAZ ≥-2 | 50 | 128.1 | 60.5 | 30.9 |
WAZ <-2 | 63 | 111.6¶ | 44.5§ | 30.9 |
HAZ ≥-2 | 60 | 127.4 | 59.7 | 30.2 |
HAZ <-2 | 53 | 109.3§ | 42.4§ | 31.6 |
Number of study participants for analyses of TC. Total N for other lipids were similar.
P-values refer to linear regression analyses used to evaluate potential correlates of lipid levels.
0.05>P<0.1.
P≤0.05.
HAART indicates highly active antiretroviral therapy; WAZ weight-for-age Z-score; HAZ, height-for-age Z-score; TC, total cholesterol, LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol; and TG, triglycerides.